Difference between revisions of "Team:Gaston Day School/Part"
HeenaSaqib (Talk | contribs) |
HeenaSaqib (Talk | contribs) |
||
| Line 27: | Line 27: | ||
.pic{ | .pic{ | ||
| − | margin-left: | + | margin-left: 500px; |
position: static; | position: static; | ||
} | } | ||
| Line 46: | Line 46: | ||
<div> | <div> | ||
| + | <h3 class="subtitle">Construct 1 (GlmY with a constitutive promoter):<h3> | ||
| + | <h4 style="margin-left: 120px;">Increase regulation of GlmZ which activates glmS expression.</h4> | ||
<img class="pic" style="height:240px ;width:480px;" src="https://static.igem.org/mediawiki/2017/7/7d/%E5%BE%AE%E4%BF%A1%E5%9B%BE%E7%89%87_20171101234321.jpg"> | <img class="pic" style="height:240px ;width:480px;" src="https://static.igem.org/mediawiki/2017/7/7d/%E5%BE%AE%E4%BF%A1%E5%9B%BE%E7%89%87_20171101234321.jpg"> | ||
| + | Figure 2 shows a characterized construct of part number BBa_K1320100. J23102 is a constitutive promoter, while K2221000 is GlmY. | ||
</div> | </div> | ||
Revision as of 03:51, 2 November 2017
Part
Baseline Corrected of Control vs. GlmY
Figure 1 shows that the plasmid carrying GlmY gives a small but significant increase in the resistance to low concentrations of isobutanol even though no promoter is present. At 60 ul isobutanol, the control had 12% survival while the culture with the GlmY plasmid had 25% survival. This increased resistance to isobutanol did not persist at higher concentrations.
Construct 1 (GlmY with a constitutive promoter):
Increase regulation of GlmZ which activates glmS expression.
Figure 2 shows a characterized construct of part number BBa_K1320100. J23102 is a constitutive promoter, while K2221000 is GlmY.
Increase regulation of GlmZ which activates glmS expression.
Figure 2 shows a characterized construct of part number BBa_K1320100. J23102 is a constitutive promoter, while K2221000 is GlmY.
